Literature DB >> 8207647

Bleach use and HIV seroconversion among New York City injection drug users.

S Titus1, M Marmor, D Des Jarlais, M Kim, H Wolfe, S Beatrice.   

Abstract

We employed a nested case-control study design to evaluate the efficacy of bleach-cleaning of needles and syringes among injecting drug users (IDUs) as a means of preventing human immunodeficiency virus (HIV) infection. Sixteen HIV-seroconverters who responded to bleach use questions and who reported injecting with shared or used equipment in the 6 months prior to their first positive visit were compared with 89 controls. Controls had remained HIV-seronegative at two or more visits, reported injecting with shared or used equipment, responded to bleach-cleaning questions, and were seen at recall visits +/- 6 months from the date of seroconversion of the index case. Risk factors associated with HIV seroconversion in univariate analyses were a history of sexual intercourse with an HIV-infected partner and the frequency of speedball (mixed heroin and cocaine) injections. After adjusting for confounders, we found no evidence that bleach use protected against HIV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207647

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  8 in total

1.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

Authors:  J Lorvick; A H Kral; K Seal; L Gee; B R Edlin
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

Authors:  H A Pollack
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Ethical issues in research on preventing HIV infection among injecting drug users.

Authors:  Don C Des Jarlais; Paul A Gaist; Samuel R Friedman
Journal:  Sci Eng Ethics       Date:  1995-04       Impact factor: 3.525

Review 4.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 5.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

6.  HIV infection in prisons. High risk behaviour is common in prisons in Berlin.

Authors:  R Müller; K Stark; I Guggenmoos-Holzmann
Journal:  BMJ       Date:  1995-05-13

7.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

8.  The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Mary M Mitchell; Eszter Ujhelyi
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.